Muntadhar Al Moosawi Gives A Talk on Chromogenic FVIII in Hemophilia A at WHX Labs Dubai
Muntadhar Al Moosawi, Consultant Hematopathology and Head of Transfusion Services and Coagulation Laboratory, shared on LinkedIn:
”Honored to be a speaker at WHX Labs Dubai, where I presented on the clinical utility of the chromogenic Factor VIII assay in hemophilia A.
My talk focused on the well-recognized discrepancies between one-stage clot-based and chromogenic assays—particularly in mild and moderate hemophilia—and the practical implications for accurate diagnosis, monitoring, and therapeutic decision-making in the era of extended half-life products and novel agents.
It was a privilege to engage with colleagues and discuss how optimized assay selection and interpretation can directly impact patient care and laboratory best practices.
Thanks to the Dr. Eiman Alzaabi and Dr. Chethan Belludi for the invitation.”

Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients